• 7ACC2: Potent Monocarboxylate Transporter 1 Inhibitor for Ca

  2026-05-09

  7ACC2 is a dual-action carboxycoumarin derivative that potently inhibits monocarboxylate transporter 1 (MCT1), disrupting lactate uptake and mitochondrial pyruvate import in cancer cells. As a validated tool in cancer metabolism research, it enables precise interrogation of metabolic vulnerabilities and enhances tumor growth delay when combined with radiotherapy. APExBIO supplies 7ACC2 as a high-purity reagent for translational and preclinical workflows.

• Dovitinib (TKI-258): Data-Driven Assay Design in RTK Cancer

  2026-05-08

  Explore how Dovitinib (TKI-258) empowers data-driven oncology research through precision targeting of RTKs and advanced assay optimization. This article uniquely applies cheminformatics insights to maximize experimental impact.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody in Quantitative Prote

  2026-05-08

  Explore how the Cy3 Goat Anti-Mouse IgG (H+L) Antibody enables sensitive, reproducible mouse IgG detection for quantitative proteomics and biomarker discovery. This article offers a unique perspective on integrating fluorescent secondary antibodies into advanced serum biomarker workflows.

• BFH772 (VEGFR2 Inhibitor): Technical Parameters & Workflow G

  2026-05-07

  BFH772 is a highly selective VEGFR2 inhibitor designed for precise inhibition of VEGFR2-driven angiogenesis, making it suitable for tumor angiogenesis and related research. It should not be used in workflows requiring water-solubility or broad-spectrum kinase inhibition due to its defined selectivity and solubility properties.

• Procainamide Hydrochloride: Dual Mechanisms in Cardiac and E

  2026-05-07

  Explore the advanced mechanisms and translational research applications of Procainamide Hydrochloride, a cardiac sodium channel blocker with emerging roles in epigenetic modulation. This article presents novel insights for cardiac electrophysiology and chemoprotection researchers.

• Cyanine 5-dCTP in Next-Gen DNA Synthesis: Precision and Insi

  2026-05-06

  Discover how Cyanine 5-dCTP empowers enzymatic oligonucleotide synthesis and DNA fluorescent probe applications with unmatched precision and sensitivity. This in-depth analysis reveals the science, protocol parameters, and unique assay benefits of Cy5-dCTP, offering insights not found in existing guides.

• Quizartinib (AC220): Advancing FLT3 Inhibition in AML Resear

  2026-05-06

  Quizartinib (AC220) delivers high selectivity and potent inhibition of FLT3, empowering acute myeloid leukemia researchers to dissect signaling and resistance at nanomolar precision. This article details optimized workflows, troubleshooting strategies, and insight-driven protocol enhancements for translational AML studies using APExBIO's trusted compound.

• Mubritinib (TAK 165): Optimizing Complex I Inhibition in Can

  2026-05-05

  Mubritinib (TAK 165) enables targeted mitochondrial inhibition and selective cytotoxicity for chemotherapy-resistant leukemia and HER2-driven cancer biology. This guide delivers workflow-validated protocols, assay optimization tips, and key insights from recent mechanistic studies for maximizing translational impact.

• Fluconazole: Precision Antifungal Workflows & Resistance Ins

  2026-05-05

  Leverage Fluconazole’s targeted mechanism as a fungal cytochrome P450 enzyme 14α-demethylase inhibitor for robust antifungal susceptibility testing and modeling drug resistance. This article delivers actionable protocols, advanced troubleshooting, and evidence-based benchmarking—empowering researchers to dissect ergosterol biosynthesis and resistance pathways with APExBIO’s trusted formulation.

• Optimizing Cell Assays with EZ Cap™ Cy5 Firefly Luciferase m

  2026-05-04

  This article delivers a scenario-driven guide for leveraging EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010) in cell viability, proliferation, and cytotoxicity workflows. Readers will discover how 5-moUTP modification, Cap1 capping, and Cy5 labeling enable reproducible, high-sensitivity dual-mode readouts, supporting robust mRNA delivery and immune evasion.

• Live-Dead Cell Staining Kit: Precision for Cell Viability As

  2026-05-04

  The Live-Dead Cell Staining Kit delivers rapid, dual-fluorescent discrimination of live and dead cells, enhancing accuracy in cell viability assays over traditional methods. Its robust Calcein-AM Propidium Iodide staining protocol empowers researchers with reproducible results across cytotoxicity, wound healing, and biomaterial workflows.

• NUAK1 Inhibition Reduces Tau p-Ser356 in Alzheimer’s Brain T

  2026-05-03

  Taylor et al. (2023) demonstrate that NUAK1-mediated phosphorylation of tau at serine 356 is closely associated with Alzheimer’s disease pathology in human brain tissue. Their work further shows that the selective NUAK1/2 inhibitor WZ4003 can lower tau p-Ser356 levels in both mouse and human ex vivo brain models, highlighting a new pharmacological strategy for dissecting tauopathy mechanisms.

• KPT330 Modulates Cas9 Specificity via mRNA Nuclear Export Co

  2026-05-02

  The referenced study demonstrates that selective inhibitors of nuclear export (SINEs), particularly KPT330, can indirectly increase the specificity of CRISPR-Cas9 genome and base editing by interfering with Cas9 mRNA export in human cells. This work identifies a novel regulatory mechanism for genome editing fidelity and expands the options for temporal control of CRISPR-based tools.

• Bobcat339: Precision TET Inhibition for Decoding Epigenetic

  2026-05-01

  Discover how Bobcat339, a cytosine structure-based TET enzyme inhibitor, enables advanced dissection of DNA methylation and gene transcription modulation. This article uniquely guides researchers in translating molecular inhibition into actionable insights for epigenetic regulatory mechanism studies.

• Azathramycin A: Macrolide Antibiotic for Tuberculosis Models

  2026-05-01

  Azathramycin A is a precision macrolide antibiotic uniquely suited for dissecting ribosomal inhibition in Mycobacterium tuberculosis. This guide details advanced experimental workflows, troubleshooting strategies, and actionable protocol parameters, empowering tuberculosis researchers to accelerate discoveries with APExBIO’s trusted compound.

15650 records 1/1044 page Next 12345 下5页 Last page